Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

Erythrocyte RBC; a nonnucleated biconcave disk approximately 7 µm in diameter, containing hemoglobin. The characteristic shape and flexible lipid membrane facilitate passage through narrow ...

However, not everyone with MS will have complications. Multiple sclerosis (MS) is a chronic (long-term) condition with symptoms that vary from person to person. With proper management of symptoms ...

If you’ve been diagnosed with multiple sclerosis (MS), it’s time to start exploring treatment options. You’ve got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

State Key Laboratory of Environmental Aquatic Chemistry, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China University of Chinese Academy of Sciences, ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Membrane trafficking is the process by which proteins and other macromolecules are distributed throughout the cell, and released to or internalised from the extracellular space. Membrane ...

Researchers compared the effects of RNA molecules delivered by EVs with and without the membrane protein to mice with ailing hearts. Only molecules carried by EVs with ion channels were able to ...

Key Laboratory of New Membrane Materials, Ministry of Industry and Information Technology, School of Environmental and Biological Engineering, Nanjing University of Science and Technology, Nanjing ...

Introduction: A pilot study assessing a novel approach to identify patients with Systemic Sclerosis (SSc) using deep learning analysis of multi-site photoplethysmography (PPG) waveforms (“DL-PPG”).